[Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]
- PMID: 15638034
[Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]
Abstract
Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone. The cardiovascular symptoms of thyrotoxicosis were described more than two hundred years ago and remained the basis of diagnosis in modern medicine. Myocardium, peripheral circulation and sympathetic nerve system, all affecting cardiovascular hemodynamics, are influenced by thyroid hormones in many ways. Sub-clinical hyperthyroidism is characterized by suppressed thyroid stimulating hormone and normal free triiodothyronine and free thyroxine levels. Cardiovascular symptoms: elevation of heart rate, myocardial contractility, stroke volume, myocardial oxygen consumption, systolic blood pressure and reduction in systemic vascular resistance and diastolic blood pressure can be often seen even in case of subclinical hyperthyroidism. Thyrotoxicosis exacerbates the symptoms of a preexisting heart disease, but it can also cause complaints in case of a structurally normal heart. The most common cardiac complications are arrhythmias (mainly atrial fibrillation), heart failure and hypertension. Amiodarone is used for the treatment and prevention of several arrhythmias. It is safely applicable even in case of left ventricular dysfunction. The more common application is limited by its side effects that can develop even at low doses and may involve several organs (thyroid gland, lungs, liver, heart, nerve system among others). The complex effect of amiodarone on thyroid function ranges from mild abnormalities of thyroid function tests to overt thyrotoxicosis or hypothyroidism.
Similar articles
-
[Thyroid and cardiovascular disorders].Pol Merkur Lekarski. 2004 May;16(95):411-4. Pol Merkur Lekarski. 2004. PMID: 15518416 Review. Polish.
-
Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.Rom J Intern Med. 2004;42(3):595-605. Rom J Intern Med. 2004. PMID: 16366133
-
Thyrotoxicosis and the cardiovascular system.Minerva Endocrinol. 2005 Jun;30(2):47-58. Minerva Endocrinol. 2005. PMID: 15988401 Review.
-
[The effects of amiodaron on the thyroid function].Pol Merkur Lekarski. 2006 Jul;21(121):86-9. Pol Merkur Lekarski. 2006. PMID: 17007301 Polish.
-
[Selective pituitary resistance to thyroid hormone in a patient treated with amiodarone].Endocrinol Nutr. 2009 Oct;56(8):418-21. doi: 10.1016/S1575-0922(09)72712-3. Endocrinol Nutr. 2009. PMID: 19959152 Spanish.
Cited by
-
Cardiovascular and Neuronal Consequences of Thyroid Hormones Alterations in the Ischemic Stroke.Metabolites. 2022 Dec 23;13(1):22. doi: 10.3390/metabo13010022. Metabolites. 2022. PMID: 36676947 Free PMC article. Review.
-
[Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].Wien Med Wochenschr. 2008;158(1-2):29-35. doi: 10.1007/s10354-007-0475-x. Wien Med Wochenschr. 2008. PMID: 18286247 Review. German.
-
Cardio-Thyrotoxicosis Syndrome: A Review of Thyrotoxic Cardiovascular Disease.Cureus. 2023 Apr 16;15(4):e37659. doi: 10.7759/cureus.37659. eCollection 2023 Apr. Cureus. 2023. PMID: 37200647 Free PMC article. Review.